Overview
We’ve all heard the global call to action to reduce our carbon footprint, improve sustainable practices, and to live within the boundaries of our planet. The pharmaceutical industry is no exception. Companies in the healthcare segment often point to their sustainability handprint in terms of positive impact on society, which is achieved by improving health and well-being. But what about the other aspects of sustainability – reduction of material consumption, clean energy usage, mitigation of greenhouse gas emissions? What are the steps that can be taken in the value chain of the healthcare segment? What actions can we as manufacturers take to make a difference to sustainability without disrupting the supply of our life-saving medicines?
In this webinar we will discuss sustainability in pharmaceutical manufacturing – but not using buzzwords or impractical KPIs. Instead, we’ll talk about pragmatic ideas for what we can do to actually drive sustainable manufacturing practices across the life cycle of pharma manufacturing - and what these practices can mean in terms of resources and cost savings. Importantly, our speakers will discuss two recent real-life case studies at Evonik: green chemistry principles in pharmaceutical process R&D; and sustainability and cost improvement through catalyst recovery by an on-scale membrane process. There will be ample opportunity to ask your questions!
Key learnings for participants
- Recap of useful guidelines and principles for pharmaceutical manufacturing
- Connection of pharmaceutical potency (handprint) and manufacturing footprint
- Insights into two case studies
- Inspiration to assess and implement measures that drive sustainability